ClearOne Reports First Quarter 2018 Financial Results
"Our revenue achievement for the first quarter of 2018 did not meet our expectations," said Zee Hakimoglu, president and chief executive officer. "The adoption of Beamforming Microphone Array 2, along with our Converge Pro 2, our new platform for professional audio conferencing, remains challenged in large part because of our competitors' product offering that directly infringes our strategic patents. We are taking action on three fronts. First and foremost, we are aggressively pursuing litigation to stop infringement of our valuable intellectual property, and we believe that we will prevail on the legal merits of our claims. Second, we are taking active measures to preserve cash, including suspending our dividend program, instituting cost-reduction plans across the company and allowing the share repurchase program to expire. And last but not the least, we are diligently developing superseding technologies and solutions to leapfrog our competition."
Financial Summary
The Company uses certain non-GAAP financial measures and reconciles those to GAAP measures in the attached tables.
- Q1 2018 revenue was
$7.3 million , compared to$11.7 million in Q1 2017 and$9.3 million in Q4 2017. The year-over-year decrease as well as sequential revenue decline reflect an impact of the on-going harm of infringement ofClearOne's patents resulting in slower adoption of our next generation professional audio conferencing platform. The patent infringement has also negatively impacted revenue fromClearOne's other products that are sold with professional audio conferencing systems. - GAAP gross profit in Q1 2018 was
$4.1 million compared to$6.7 million in Q1 2017 and$4.8 million in Q4 2017. GAAP gross profit margin was 56% in Q1 2018, compared to 57% in Q1 2017 and 51% in Q4 2017. Sequential improvement in gross margin was mainly due to reduced inventory obsolescence costs. - Operating expenses in Q1 2018 were
$6.5 million , compared to$7.2 million in Q1 2017 and$5.8 million in Q4 2017 which included a receipt of$0.8 million from a legal settlement which reduced the operating expenses. The majority of the decrease in operating expenses over Q1 2017 is attributable to reduced legal expenses, capitalization of legal expenses related to patent litigation and reduced R&D related project expenses. Non-GAAP operating expenses in Q1 2018 were$6.1 million , compared to$6.3 million in Q1 2017 and$6.1 million in Q4 2017. The year over year decrease in Non-GAAP operating expenses was mainly due to the decrease in R&D expenditure. - GAAP net loss in Q1 2018 was
$1.8 million , or$0.22 per share, compared to net loss of$0.5 million , or$0.05 per share, in Q1 2017 and net loss of$3.6 million , or$0.43 per share, in Q4 2017. Net loss in Q1 2018 was largely caused by the reduction in revenue and associated gross profit. Non-GAAP net loss was$1.5 million , or$0.18 per share, in Q1 2018, compared to non-GAAP net income of$0.1 million in Q1 2017 and net loss of$2.3 million , or$0.27 per share, in Q4 2017. Non-GAAP net loss in Q1 2018 was caused by lower revenues and reduction in associated gross margin.
Financial Summary |
|||||||
($ in 000, except per share) |
Three months ended March 31, |
||||||
2018 |
2017 |
Change |
|||||
GAAP |
|||||||
Revenue |
$ |
7,289 |
$ |
11,678 |
-38% |
||
Gross Profit |
4,099 |
6,678 |
-39% |
||||
Operating loss |
(2,442) |
(526) |
-364% |
||||
Net loss |
(1,846) |
(468) |
-294% |
||||
Diluted loss per share |
(0.22) |
(0.05) |
-340% |
||||
Non-GAAP |
|||||||
Non-GAAP Gross Profit |
$ |
4,104 |
$ |
6,686 |
-39% |
||
Non-GAAP Operating Income (Loss) |
(1,957) |
366 |
-635% |
||||
Non-GAAP Net Income (Loss) |
(1,466) |
149 |
-1084% |
||||
Non-GAAP Adjusted EBITDA |
(1,801) |
634 |
-384% |
||||
Non-GAAP Earnings (Loss) per share (Diluted) |
(0.18) |
0.02 |
-1000% |
Balance Sheet Highlights
At
During Q1 of 2018, the Company paid a cash dividend of
The Board of Directors has decided not to renew the repurchase program which terminated in
About
Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a GAAP basis,
Forward Looking Statements
This release contains "forward-looking" statements that are based on present circumstances and on
Contact:
Investor Relations
801-975-7200
investor_relations@clearone.com
http://investors.clearone.com
CLEARONE, INC |
||||||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||
(Dollars in thousands, except par value) |
||||||
As at |
||||||
March 31, 2018 |
December 31, 2017 |
|||||
ASSETS |
||||||
Current assets: |
||||||
Cash and cash equivalents |
$ |
5,577 |
$ |
5,571 |
||
Marketable securities |
3,132 |
2,689 |
||||
Receivables, net of allowance for doubtful accounts of $491 and $472, respectively |
6,247 |
7,794 |
||||
Inventories, net |
14,622 |
14,415 |
||||
Distributor channel inventories |
— |
1,555 |
||||
Prepaid expenses and other assets |
1,963 |
1,862 |
||||
Total current assets |
31,541 |
33,886 |
||||
Long-term marketable securities |
7,416 |
10,349 |
||||
Long-term inventories, net |
8,565 |
8,708 |
||||
Property and equipment, net |
1,481 |
1,549 |
||||
Intangibles, net |
7,640 |
6,543 |
||||
Deferred income taxes |
7,227 |
6,531 |
||||
Other assets |
316 |
311 |
||||
Total assets |
$ |
64,186 |
$ |
67,877 |
||
LIABILITIES AND SHAREHOLDERS' EQUITY |
||||||
Current liabilities: |
||||||
Accounts payable |
$ |
4,295 |
$ |
4,122 |
||
Accrued liabilities |
1,975 |
1,843 |
||||
Deferred product revenue |
282 |
4,635 |
||||
Total current liabilities |
6,552 |
10,600 |
||||
Deferred rent |
81 |
103 |
||||
Other long-term liabilities |
679 |
607 |
||||
Total liabilities |
7,312 |
11,310 |
||||
Shareholders' equity: |
||||||
Common stock, par value $0.001, 50,000,000 shares authorized, 8,301,273 and 8,319,022 shares issued and outstanding |
8 |
8 |
||||
Additional paid-in capital |
47,612 |
47,464 |
||||
Accumulated other comprehensive income (loss) |
(113) |
(65) |
||||
Retained earnings |
9,367 |
9,160 |
||||
Total shareholders' equity |
56,874 |
56,567 |
||||
Total liabilities and shareholders' equity |
$ |
64,186 |
$ |
67,877 |
CLEARONE, INC. |
||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||
(Dollars in thousands, except per share values) |
||||||
Three months ended March 31, |
||||||
2018 |
2017 |
|||||
Revenue |
$ |
7,289 |
$ |
11,678 |
||
Cost of goods sold |
3,190 |
5,000 |
||||
Gross profit |
4,099 |
6,678 |
||||
Operating expenses: |
||||||
Sales and marketing |
2,868 |
2,741 |
||||
Research and product development |
2,056 |
2,357 |
||||
General and administrative |
1,617 |
2,106 |
||||
Total operating expenses |
6,541 |
7,204 |
||||
Operating loss |
(2,442) |
(526) |
||||
Other income, net |
24 |
102 |
||||
Loss before income taxes |
(2,418) |
(424) |
||||
Provision for (benefit from) income taxes |
(572) |
44 |
||||
Net loss |
$ |
(1,846) |
$ |
(468) |
||
Basic weighted average shares outstanding |
8,307,125 |
8,768,112 |
||||
Diluted weighted average shares outstanding |
8,307,125 |
8,768,112 |
||||
Basic loss per share |
$ |
(0.22) |
$ |
(0.05) |
||
Diluted loss per share |
$ |
(0.22) |
$ |
(0.05) |
||
Net loss |
(1,846) |
(468) |
||||
Comprehensive income: |
||||||
Unrealized gain (loss) on available-for-sale securities, net of tax |
(70) |
38 |
||||
Change in foreign currency translation adjustment |
22 |
12 |
||||
Comprehensive loss |
(1,894) |
(418) |
CLEARONE, INC. |
|||||||
UNAUDITED RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES |
|||||||
(Dollars in thousands, except per share values) |
|||||||
Three months ended March 31, |
|||||||
2018 |
2017 |
||||||
GAAP gross profit |
$ |
4,099 |
$ |
6,678 |
|||
Stock-based compensation |
5 |
8 |
|||||
Non-GAAP gross profit |
$ |
4,104 |
$ |
6,686 |
|||
GAAP operating income (loss) |
$ |
(2,442) |
$ |
(526) |
|||
Stock-based compensation |
137 |
171 |
|||||
Amortization of intangibles |
248 |
237 |
|||||
Legal expenses, acquisition expenses, restructuring expenses, etc. not related to regular operations |
100 |
484 |
|||||
Non-GAAP operating income (loss) |
$ |
(1,957) |
$ |
366 |
|||
GAAP net income (loss) |
$ |
(1,846) |
$ |
(468) |
|||
Stock-based compensation |
137 |
171 |
|||||
Amortization of intangibles |
248 |
237 |
|||||
Legal expenses, acquisition expenses, restructuring expenses, etc. not related to regular operations |
100 |
484 |
|||||
Tax effect of non-GAAP adjustments |
(105) |
(275) |
|||||
Non-GAAP net income (loss) |
$ |
(1,466) |
$ |
149 |
|||
GAAP net income (loss) |
$ |
(1,846) |
$ |
(468) |
|||
Number of shares used in computing GAAP income per share (diluted) |
8,307,125 |
8,768,112 |
|||||
GAAP income (loss) per share (diluted) |
$ |
(0.22) |
$ |
(0.05) |
|||
Non-GAAP net income (loss) |
$ |
(1,466) |
$ |
149 |
|||
Number of shares used in computing Non-GAAP income per share (diluted) |
8,307,125 |
8,768,112 |
|||||
Non-GAAP income (loss) per share (diluted) |
$ |
(0.18) |
$ |
0.02 |
|||
GAAP total net income (loss) |
$ |
(1,846) |
$ |
(468) |
|||
Stock-based compensation |
137 |
171 |
|||||
Depreciation |
132 |
166 |
|||||
Amortization of intangibles |
248 |
237 |
|||||
Legal expenses, acquisition expenses, restructuring expenses, etc. not related to regular operations |
100 |
484 |
|||||
Provision for (benefit from) income taxes |
(572) |
44 |
|||||
Non-GAAP Adjusted EBITDA |
$ |
(1,801) |
$ |
634 |
View original content with multimedia:http://www.prnewswire.com/news-releases/clearone-reports-first-quarter-2018-financial-results-300666202.html
SOURCE